VEGFA and ischemia: We employed deferoxamine (DFO) to simulate hypoxia, which enhanced the expression of key wound‐healing mediators, particularly miRNA‐9 (a critical neurogenesis regulator) and vascular endothelial growth factor (VEGF)[15] (thus addressing ischemia while promoting angiogenesis and BBB restoration) (Figure 1b).